Related references
Note: Only part of the references are listed.Effects of the 10-Valent Pneumococcal Nontypeable Haemophilus influenzae Protein D-Conjugate Vaccine on Nasopharyngeal Bacterial Colonization in Young Children: A Randomized Controlled Trial
Menno R. van den Bergh et al.
CLINICAL INFECTIOUS DISEASES (2013)
Capsular Gene Sequences and Genotypes of Serotype 6E Streptococcus pneumoniae Isolates
Kwan Soo Ko et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2013)
Effectiveness of the ten-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine (PHiD-CV10) against invasive pneumococcal disease: a cluster randomised trial
Arto A. Palmu et al.
LANCET (2013)
Immunogenicity and Safety of a 13-Valent Pneumococcal Conjugate Vaccine in Healthy Infants and Toddlers Given With Routine Vaccines in India
Yeshwant K. Amdekar et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2013)
Pneumococcal Carriage and Invasive Disease in Children Before Introduction of the 13-valent Conjugate Vaccine: Comparison With the Era Before 7-valent Conjugate Vaccine
Dolly Sharma et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2013)
Three-year Antibody Persistence and Safety After a Single Dose of Combined Haemophilus influenzae Type b (Hib)-Neisseria meningitidis Serogroup C-tetanus Toxoid Conjugate Vaccine in Hib-primed Toddlers
Robert Booy et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2013)
Pneumococcal Serotypes before and after Introduction of Conjugate Vaccines, United States, 1999 2011
Sandra S. Richter et al.
EMERGING INFECTIOUS DISEASES (2013)
Dose-specific efficacy of Haemophilus influenzae type b conjugate vaccines: a systematic review and meta-analysis of controlled clinical trials
U. K. Griffiths et al.
EPIDEMIOLOGY AND INFECTION (2012)
A Randomized Trial to Assess Safety and Immunogenicity of Alternative Formulations of a Quadrivalent Meningococcal (A, C, Y, and W-135) Tetanus Protein Conjugate Vaccine in Toddlers
Jodie McVernon et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2012)
Impact of 13-valent Pneumococcal Conjugate Vaccine on Pneumococcal Nasopharyngeal Carriage in Children With Acute Otitis Media
Robert Cohen et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2012)
Antibody Persistence After a Primary Series of a New DTaP-IPV-Hep B- PRP-T Combined Vaccine or Separate DTaP-IPV//PRP-T and Hepatitis B Vaccines at 2, 4, and 6 Months of Age and the Effect of a Subsequent DTaP-IPV//PRP-T Booster Vaccination at 18 Months of Age in Healthy Argentinean Infants
Marcelo Tregnaghi et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2012)
Safety and Immunogenicity of a Quadrivalent Meningococcal Polysaccharide Diphtheria Toxoid Conjugate Vaccine in Infants and Toddlers: Three Multicenter Phase III Studies
L. Miriam Pina et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2012)
Safety and Immunogenicity of a Novel Quadrivalent Meningococcal CRM-conjugate Vaccine Given Concomitantly With Routine Vaccinations in Infants
Nicola P. Klein et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2012)
Safety and Immunogenicity of a 13-valent Pneumococcal Conjugate Vaccine in Healthy Infants and Toddlers Given With Routine Pediatric Vaccinations in Canada
Otto G. Vanderkooi et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2012)
Induction of Immunologic Memory Following Primary Vaccination With the 10-valent Pneumococcal Nontypeable Haemophilus influenzae Protein D Conjugate Vaccine in Infants
Markus Knuf et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2012)
Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine given with routine pediatric vaccines in Taiwan
Li-Min Huang et al.
VACCINE (2012)
A randomized study to assess the immunogenicity, antibody persistence and safety of a tetravalent meningococcal serogroups A, C, W-135 and Y tetanus toxoid conjugate vaccine in children aged 2-10 y
Timo Vesikari et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2012)
The immunogenicity and safety of an investigational meningococcal serogroups A, C, W-135, Y tetanus toxoid conjugate vaccine (ACWY-TT) compared with a licensed meningococcal tetravalent polysaccharide vaccine A randomized, controlled non-inferiority study
Ghassan Dbaibo et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2012)
Kinetics of Immune Responses to Nasal Challenge With Meningococcal Polysaccharide One Year After Serogroup-C Glycoconjugate Vaccination
James B. Wing et al.
CLINICAL INFECTIOUS DISEASES (2011)
A Randomized Study Comparing Combined Pneumococcal Conjugate and Polysaccharide Vaccination Schedules in Adults
Rajeka Lazarus et al.
CLINICAL INFECTIOUS DISEASES (2011)
Kinetics of the Antibody Response to Tetanus-Diphtheria-Acellular Pertussis Vaccine in Women of Childbearing Age and Postpartum Women
B. A. Halperin et al.
CLINICAL INFECTIOUS DISEASES (2011)
Next generation pneumococcal vaccines
Kristin L. Moffitt et al.
CURRENT OPINION IN IMMUNOLOGY (2011)
Safety and immunogenicity of a tetravalent meningococcal serogroups A, C, W-135 and Y conjugate vaccine in adolescents and adults
Nancy Bermal et al.
HUMAN VACCINES (2011)
Co-administration of a novel Haemophilus influenzae type b and Neisseria meningitidis serogroups C and Y-tetanus toxoid conjugate vaccine does not interfere with the immune response to antigens contained in infant vaccines routinely used in the United States
Gary S. Marshall et al.
HUMAN VACCINES (2011)
Shifting Genetic Structure of Invasive Serotype 19A Pneumococci in the United States
Bernard W. Beall et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
Serotype replacement in disease after pneumococcal vaccination
Daniel M. Weinberger et al.
LANCET (2011)
Effectiveness of Serogroup C Meningococcal Conjugate Vaccine A 7-Year Follow-up in Quebec, Canada
Philippe De Wals et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2011)
Immunogenicity of a Single Dose of Tetravalent Meningococcal Serogroups A, C, W-135, and Y Conjugate Vaccine Administered to 2-to 10-year-olds Is Noninferior to a Licensed-ACWY Polysaccharide Vaccine With an Acceptable Safety Profile
Ziad A. Memish et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2011)
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal ACWY Tetanus Toxoid Conjugate Vaccine in Healthy Adolescents and Young Adults 10 to 25 Years of Age
Roger Baxter et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2011)
Persistence of Serum Bactericidal Antibody One Year After a Booster Dose of Either a Glycoconjugate or a Plain Polysaccharide Vaccine Against Serogroup C Neisseria meningitidis Given to Adolescents Previously Immunized With a Glycoconjugate Vaccine
Philip C. S. de Whalley et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2011)
Immunogenicity and Safety of an Investigational Combined Haemophilus influenzae Type B-Neisseria meningitidis Serogroups C and Y-Tetanus Toxoid Conjugate Vaccine
Terry Nolan et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2011)
Tetravalent meningococcal serogroups A, C, W-135 and Y conjugate vaccine is well tolerated and immunogenic when co-administered with measles-mumps-rubella-varicella vaccine during the second year of life: An open, randomized controlled trial
Timo Vesikari et al.
VACCINE (2011)
Impact of the 10-valent pneumococcal non-typeable Haemophilus influenzae Protein D conjugate vaccine (PHiD-CV) on bacterial nasopharyngeal carriage
Roman Prymula et al.
VACCINE (2011)
Carriage of Streptococcus pneumoniae 3 Years after Start of Vaccination Program, the Netherlands
Judith Spijkerman et al.
EMERGING INFECTIOUS DISEASES (2011)
Kinetics of Antibody Persistence following Administration of a Combination Meningococcal Serogroup C and Haemophilus influenzae Type b Conjugate Vaccine in Healthy Infants in the United Kingdom Primed with a Monovalent Meningococcal Serogroup C Vaccine
Ray Borrow et al.
CLINICAL AND VACCINE IMMUNOLOGY (2010)
Randomized Trial on the Safety, Tolerability, and Immunogenicity of MenACWY-CRM, an Investigational Quadrivalent Meningococcal Glycoconjugate Vaccine, Administered Concomitantly with a Combined Tetanus, Reduced Diphtheria, and Acellular Pertussis Vaccine in Adolescents and Young Adults
Roberto Gasparini et al.
CLINICAL AND VACCINE IMMUNOLOGY (2010)
Safety and Immunogenicity of a 13-Valent Pneumococcal Conjugate Vaccine Compared to Those of a 7-Valent Pneumococcal Conjugate Vaccine Given as a Three-Dose Series with Routine Vaccines in Healthy Infants and Toddlers
Susanna Esposito et al.
CLINICAL AND VACCINE IMMUNOLOGY (2010)
Antibody Persistence after Serogroup C Meningococcal Conjugate Immunization of United Kingdom Primary-School Children in 1999-2000 and Response to a Booster: A Phase 4 Clinical Trial
K. P. Perrett et al.
CLINICAL INFECTIOUS DISEASES (2010)
Safety and immunogenicity of an investigational quadrivalent meningococcal conjugate vaccine after one or two doses given to infants and toddlers
S. A. Halperin et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2010)
Persistence of immune responses after a single dose of Novartis meningococcal serogroup A, C, W-135 and Y CRM-197 conjugate vaccine (Menveo®) or Menactra® among healthy adolescents
Christopher J. Gill et al.
HUMAN VACCINES (2010)
Safety and immunogenicity of an investigational quadrivalent meningococcal CRM197 conjugate vaccine, MenACWY-CRM, compared with licensed vaccines in adults in Latin America
D. Stamboulian et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2010)
Immunogenicity and Reactogenicity of a 13-Valent-pneumococcal Conjugate Vaccine Administered at 2, 4, and 12 Months of Age A Double-blind Randomized Active-controlled Trial
Matthew D. Snape et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2010)
Safety and Immunogenicity of a 13-Valent Pneumococcal Conjugate Vaccine
Kristina A. Bryant et al.
PEDIATRICS (2010)
Immunogenicity and Safety of 13-Valent Pneumococcal Conjugate Vaccine in Infants and Toddlers
Sylvia H. Yeh et al.
PEDIATRICS (2010)
Safety and immunogenicity of one dose of MenACWY-CRM, an investigational quadrivalent meningococcal glycoconjugate vaccine, when administered to adolescents concomitantly or sequentially with Tdap and HPV vaccines
A. Arguedas et al.
VACCINE (2010)
A dose-range study assessing immunogenicity and safety of one dose of a new candidate meningococcal serogroups A, C, W-135, Y tetanus toxoid conjugate (MenACWY-TT) vaccine administered in the second year of life and in young children
M. Knuf et al.
VACCINE (2010)
Immunogenicity and tolerability of a quadrivalent meningococcal glycoconjugate vaccine in children 2-10 years of age
S. Black et al.
VACCINE (2010)
Safety, tolerability, and immunologic noninferiority of a 13-valent pneumococcal conjugate vaccine compared to a 7-valent pneumococcal conjugate vaccine given with routine pediatric vaccinations in Germany
Dorothee M. Kieninger et al.
VACCINE (2010)
Quadrivalent Meningococcal Vaccination of Adults: Phase III Comparison of an Investigational Conjugate Vaccine, MenACWY-CRM, with the Licensed Vaccine, Menactra
Keith S. Reisinger et al.
CLINICAL AND VACCINE IMMUNOLOGY (2009)
Immunogenicity and Reactogenicity of Pneumococcal Polysaccharide and Conjugate Vaccines in Alaska Native Adults 55-70 Years of Age
Karen M. Miernyk et al.
CLINICAL INFECTIOUS DISEASES (2009)
Randomized Study of Early versus Late Immunization with Pneumococcal Conjugate Vaccine after Allogeneic Stem Cell Transplantation
Catherine Cordonnier et al.
CLINICAL INFECTIOUS DISEASES (2009)
Phase III Comparison of an Investigational Quadrivalent Meningococcal Conjugate Vaccine with the Licensed Meningococcal ACWY Conjugate Vaccine in Adolescents
Lisa A. Jackson et al.
CLINICAL INFECTIOUS DISEASES (2009)
Quantitative and Qualitative Anamnestic Immune Responses to Pneumococcal Conjugate Vaccine in HIV-Infected and HIV-Uninfected Children 5 Years after Vaccination
Shabir A. Madhi et al.
JOURNAL OF INFECTIOUS DISEASES (2009)
Immunogenicity and Immune Memory of a Nonadjuvanted Quadrivalent Meningococcal Glycoconjugate Vaccine in Infants
Kirsten P. Perrett et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2009)
The Impact of Childhood Meningococcal Serogroup C Conjugate Vaccine Programs in Canada
Julie A. Bettinger et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2009)
Nasopharyngeal Carriage of Streptococcus pneumoniae in Gambian Children who Participated in a 9-valent Pneumococcal Conjugate Vaccine Trial and in Their Younger Siblings
Yin-Bun Cheung et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2009)
A Randomized Trial to Determine the Tolerability and Immunogenicity of a Quadrivalent Meningococcal Glycoconjugate Vaccine in Healthy Adolescents
Lisa A. Jackson et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2009)
Immunogenicity of a 2-Dose Priming and Booster Vaccination With the 10-Valent Pneumococcal Nontypeable Haemophilus influenzae Protein D Conjugate Vaccine
Sven Arne Silfverdal et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2009)
Immunogenicity of Routinely Used Childhood Vaccines When Coadministered With the 10-Valent Pneumococcal Non-typeable Haemophilus influenzae Protein D Conjugate Vaccine (PHiD-CV)
Markus Knuf et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2009)
Immunogenicity of the 10-Valent Pneumococcal Non-typeable Haemophilus influenzae Protein D Conjugate Vaccine (PHiD-CV) Compared to the Licensed 7vCRM Vaccine
Timo Vesikari et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2009)
Continued Impact of Pneumococcal Conjugate Vaccine on Carriage in Young Children
Susan S. Huang et al.
PEDIATRICS (2009)
Booster Vaccinations: Can Immunologic Memory Outpace Disease Pathogenesis?
Michael E. Pichichero
PEDIATRICS (2009)
Immunogenicity, reactogenicity and persistence of meningococcal A, C, W-135 and Y-tetanus toxoid candidate conjugate (MenACWY-TT) vaccine formulations in adolescents aged 15-25 years
Lars Ostergaard et al.
VACCINE (2009)
Indirect effect of 7-valent pneumococcal conjugate vaccine on pneumococcal colonization among unvaccinated household members
Eugene V. Millar et al.
CLINICAL INFECTIOUS DISEASES (2008)
Haemophilus influenzae type b vaccine failure in children is associated with inadequate production of high-quality antibody
Yeh Chen Lee et al.
CLINICAL INFECTIOUS DISEASES (2008)
Correlates of vaccine-induced immunity
Stanley A. Plotkin
CLINICAL INFECTIOUS DISEASES (2008)
Immunogenicity of a tetravalent meningococcal glycoconjugate vaccine in infants - A randomized controlled trial
Matthew D. Snape et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2008)
The magnitude of the antibody and memory B cell responses during priming with a protein-polysaccharide conjugate vaccine in human infants is associated with the persistence of antibody and the intensity of booster responsele
Geraldine Blanchard Rohner et al.
JOURNAL OF IMMUNOLOGY (2008)
Initial and subsequent response to pneumococcal polysaccharide and protein-conjugate vaccines administered sequentially to adults who have recovered from pneumococcal pneumonia
Daniel M. Musher et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
Impact of meningococcal serogroup C conjugate vaccines on carriage and herd immunity
Martin C. J. Maiden et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
TRENDS IN NASOPHARYNGEAL CARRIAGE OF STREPTOCOCCUS PNEUMONIAE AMONG CHILDREN ATTENDING DAYCARE CENTERS IN SOUTHEASTERN FRANCE FROM 1999 TO 2006
Brigitte Dunais et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2008)
Safety of the 11-valent pneumococcal vaccine conjugated to non-typeable Haemophilus influenzae-derived protein D in the first 2 years of life and immunogenicity of the co-administered hexavalent diphtheria, tetanus, acellular pertussis, hepatitis B, inactivated polio virus, Haemophilus influenzae type b and control hepatitis A vaccines
Roman Prymula et al.
VACCINE (2008)
Emergence of a multiresistant serotype 19A pneumococcal strain not included in the 7-valent conjugate vaccine as an otopathogen in children
Michael E. Pichichero et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
Quality of the haemophilus influenzae type b (Hib) antibody response induced by diphtheria-tetanus-acellular Pertussis/Hib combination vaccines
Philippe A. Denoel et al.
CLINICAL AND VACCINE IMMUNOLOGY (2007)
Safety, immunogenicity, and antibody persistence of a new meningococcal group A conjugate vaccine in healthy Indian adults
Nilima Kshirsagar et al.
VACCINE (2007)
Herd immunity and pneumococcal conjugate vaccine: A quantitative model
Michael Haber et al.
VACCINE (2007)
Anticapsular serum antibody concentration and protection against pneumococcal colonization among children vaccinated with 7-valent pneumococcal conjugate vaccine
Eugene V. Millar et al.
CLINICAL INFECTIOUS DISEASES (2007)
Functional antibodies elicited by two heptavalent pneumococcal conjugate vaccines in the Finnish Otitis Media Vaccine Trial
Nina Ekstrom et al.
INFECTION AND IMMUNITY (2007)
A surveillance network for meningococcal disease in Europe
Caroline L. Trotter et al.
FEMS MICROBIOLOGY REVIEWS (2007)
Clinical and immunologic risk factors for meningococcal C conjugate vaccine failure in the United Kingdom
Cressida Auckland et al.
JOURNAL OF INFECTIOUS DISEASES (2006)
Serogroup C meningococcal glycoconjugate vaccine in adolescents: Persistence of bactericidal antibodies and kinetics of the immune response to a booster vaccine more than 3 years after immunization
Matthew D. Snape et al.
CLINICAL INFECTIOUS DISEASES (2006)
Immune memory in children previously vaccinated with an experimental quadrivalent meningococcal polysaccharide diphtheria toxoid conjugate vaccine
Michael Pichichero et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2006)
Impact of pneumococcal conjugate vaccine and of reduction of antibiotic use on nasopharyngeal carriage of nonsusceptible pneumococci in children with acute otitis media
Robert Cohen et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2006)
Effectiveness of seven-valent pneumococcal conjugate vaccine against invasive pneumococcal disease: a matched case-control study
Cynthia G. Whitney et al.
LANCET (2006)
The Alaska Haemophilus influenzae type b experience:: Lessons in controlling a vaccine-preventable diseaseD
Rosalyn Singleton et al.
PEDIATRICS (2006)
Epidemiology of meningococcal disease in England and Wales 1993/94 to 2003/04: contribution and experiences of the Meningococcal Reference Unit
Stephen J. Gray et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2006)
Indirect effect of conjugate vaccine on adult carriage of Streptococcus pneumoniae:: An explanation of trends in invasive pneumococcal disease
LL Hammitt et al.
JOURNAL OF INFECTIOUS DISEASES (2006)
Immunogenicity and boosting after a reduced number of doses of a pneumococcal conjugate vaccine in infants and toddlers
D Goldblatt et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2006)
Pneumococcal capsular polysaccharides conjugated to protein D for prevention of acute otitis media caused by both Streptococcus pneumoniae and non-typable Haemophilus influenzae:: a randomised double-blind efficacy study
R Prymula et al.
LANCET (2006)
Protection from routine vaccination at the age of 14 months with meningococcal serogroup C conjugate vaccine in the Netherlands
SC de Greeff et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2006)
Nasopharyngeal colonization with heptavalent pneumococcal conjugate vaccine serotypes of Streptococcus pneumonicie with prolonged vaccine dosing intervals
VF Jones et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2005)
Safety, immunogenicity, and immune memory of a novel meningococcal (groups A, C, Y, and W-135) polysaccharide diphtheria toxoid conjugate vaccine (MCV-4) in healthy adolescents
H Keyserling et al.
ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE (2005)
Post-PCV7 changes in colonizing pneumococcal serotypes in 16 Massachusetts communities, 2001 and 2004
SS Huang et al.
PEDIATRICS (2005)
Serum serotype-specific pneumococcal anticapsular immunoglobulin g concentrations after immunization with a 9-valent conjugate pneumococcal vaccine correlate with nasopharyngeal acquisition of pneumococcus
R Dagan et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
Effectiveness of serogroup C meningococcal polysaccharide vaccine:: Results from a case-control study in Quebec
P De Wals et al.
CLINICAL INFECTIOUS DISEASES (2005)
Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trial
FT Cutts et al.
LANCET (2005)
Double-blind study comparing the immunogenicity of a licensed DTwPHib-CRM197 conjugate vaccine (Quattvaxem™) with three investigational, liquid formulations using lower doses of Hib-CRM197 conjugate
E Tamm et al.
VACCINE (2005)
Immunogenicity and tolerability of a heptavalent pneumococcal conjugate vaccine administered at 3, 5 and 12 months of age
H Käyhty et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2005)
Persistence of group C anticapsular antibodies two to three years after immunization with an investigational quadrivalent Neisseria meningitidis-diphtheria toxoid conjugate vaccine
DM Granoff et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2005)
Comparative trial of the safety and immunogenicity of quadrivalent (A, C, Y, W-135) meningococcal polysaccharide-diphtheria conjugate vaccine versus quadrivalent polysaccharicle vaccine in two- to ten-year-old children
M Pichichero et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2005)
Tolerability and immunogenicity of an eleven valent mixed carrier Streptococcus pneumoniae capsular polysaccharide-diphtheria toxoid or tetanus protein conjugate vaccine in Finnish and Israeli infants
R Dagan et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2004)
Haemophilus influenzae type b conjugate vaccines
DF Kelly et al.
IMMUNOLOGY (2004)
Generation and maintenance of immunological memory
TS Gourley et al.
SEMINARS IN IMMUNOLOGY (2004)
Effect of the 7-valent pneumococcal conjugate vaccine on nasopharyngeal colonization by Streptococcus pneumoniae in the first 2 years of life
F Ghaffar et al.
CLINICAL INFECTIOUS DISEASES (2004)
Reduction of antibody response to an 11-valent pneumococcal vaccine coadministered with a vaccine containing acellular pertussis components
R Dagan et al.
INFECTION AND IMMUNITY (2004)
Dose response of CRM197 and tetanus toxoid-conjugated Haemophilus influenzae type b vaccines
RE Huebner et al.
VACCINE (2004)
Effectiveness of meningococcal serogroup C conjugate vaccine 4 years after introduction
CL Trotter et al.
LANCET (2004)
Impact of a conjugate vaccine on community-wide carriage of nonsusceptible Streptococcus pneumoniae in Alaska
MR Moore et al.
JOURNAL OF INFECTIOUS DISEASES (2004)
Effectiveness of a mass immunization campaign using serogroup C meningococcal conjugate vaccine
P De Wals et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)
Postlicensure surveillance for pneumococcal invasive disease after use of heptavalent pneumococcal conjugate vaccine in Northern California Kaiser Permanente
S Black et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2004)
Seven valent pneumococcal conjugate vaccine immunization in two Boston communities -: Changes in serotypes and antimicrobial susceptibility among Streptococcus pneumoniae isolates
SI Pelton et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2004)
Similar antibody concentrations in Filipino infants at age 9 months, after 1 or 3 doses of an adjuvanted, 11-valent pneumococcal diphtheria/tetanus-conjugated vaccine:: A randomized controlled trial
MG Lucero et al.
JOURNAL OF INFECTIOUS DISEASES (2004)
Protective activity of group C anticapsular antibodies elicited in two-year-olds by an investigational quadrivalent Neisseria meningitidis-diphtheria toxoid conjugate vaccine
DM Granoff et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2004)
Dosage escalation, safety and immunogenicity study of four dosages of a tetravalent meninogococcal polysaccharide diphtheria toxoid conjugate vaccine in infants
M Rennels et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2004)
A trial of a 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection
KP Klugman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Immunogenicity of, and immunologic memory to, a reduced primary schedule of meningococcal C-tetanus toxoid conjugate vaccine in infants in the United Kingdom
R Borrow et al.
INFECTION AND IMMUNITY (2003)
The safety, reactogenicity and immunogenicity of a 7-valent pneumococcal conjugate vaccine (7VPnC) concurrently administered with a combination DTaP-IPV-Hib vaccine
HJ Schmitt et al.
VACCINE (2003)
Estimating Haemophilus influenzae type b vaccine effectiveness in England and Wales by use of the screening method
ME Ramsay et al.
JOURNAL OF INFECTIOUS DISEASES (2003)
Efficacy and safety of seven-valent conjugate pneumococcal vaccine in American Indian children: group randomised trial
KL O'Brien et al.
LANCET (2003)
Safety and immunogenicity of a heptavalent pneumococcal conjugate vaccine in infants with human immunodeficiency virus type 1 infection
S Nachman et al.
PEDIATRICS (2003)
Functional antibodies elicited by an 11-valent diphtheria-tetanus toxoid-conjugated pneumococcal vaccine
T Puumalainen et al.
JOURNAL OF INFECTIOUS DISEASES (2003)
Disparity in functional activity between serum anticapsular antibodies induced in adults by immunization with an investigational group A and C Neisseria meningitidis-diphtheria toxoid conjugate vaccine and by a polysaccharide vaccine
SL Harris et al.
INFECTION AND IMMUNITY (2003)
Safety and immunogenicity of a heptavalent pneumococcal conjugate vaccine in infants
KM Zangwill et al.
VACCINE (2003)
Randomized, double-blind, controlled trial of pneumococcal vaccination in renal transplant recipients
D Kumar et al.
JOURNAL OF INFECTIOUS DISEASES (2003)
Risk of vaccine failure after Haemophilus influenzae type b (Hib) combination vaccines with acellular pertussis
J McVernon et al.
LANCET (2003)
Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine
CG Whitney et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Immunogenicity and immunological priming of the serogroup a portion of a bivalent meningococcal A/C conjugate vaccine in 2-year-old children
H Joseph et al.
JOURNAL OF INFECTIOUS DISEASES (2003)
Herd immunity from meningococcal serogroup C conjugate vaccination in England: database analysis
ME Ramsay et al.
BRITISH MEDICAL JOURNAL (2003)
Greater antibody responses to an eleven valent mixed carrier diphtheria- or tetanus-conjugated pneumococcal vaccine in Filipino than in Finnish or Israeli infants
T Puumalainen et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2003)
Protective efficacy of a second pneumococcal conjugate vaccine against pneumococcal acute otitis media in infants and children: Randomized, controlled trial of a 7-valent pneumococcal polysaccharide-meningococcal outer membrane protein complex conjugate vaccine in 1666 children
T Kilpi et al.
CLINICAL INFECTIOUS DISEASES (2003)
Safety, reactogenicity, and immunogenicity of a tetravalent meningococcal polysaccharide-diphtheria toxoid conjugate vaccine given to healthy adults
JD Campbell et al.
JOURNAL OF INFECTIOUS DISEASES (2002)
Induction of functional secretory IgA responses in breast milk, by pneumococcal capsular polysaccharides
A Finn et al.
JOURNAL OF INFECTIOUS DISEASES (2002)
Antibody persistence and immunological memory at age 4 years after meningococcal group C conjugate vaccination in children in the United Kingdom
R Borrow et al.
JOURNAL OF INFECTIOUS DISEASES (2002)
Immunogenicity after one, two or three doses and impact on the antibody response to coadministered antigens of a nonavalent pneumococcal conjugate vaccine in infants of Soweto, South Africa
RE Huebner et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2002)
Dose escalation, safety and immunogenicity study of a tetravalent meninogococcal polysaccharide diphtheria conjugate vaccine in toddlers
M Rennels et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2002)
Safety and immunogenicity of pneumococcal conjugate vaccine in combination with diphtheria, tetanus toxoid, pertussis and Haemophilus influenzae type b conjugate vaccine
SK Obaro et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2002)
Effectiveness of heptavalent pneumococcal conjugate vaccine in children younger than five years of age for prevention of pneumonia
SB Black et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2002)
Effect of vaccination with carrier protein on response to meningococcal C conjugate vaccines and value of different immunoassays as predictors of protection
M Burrage et al.
INFECTION AND IMMUNITY (2002)
Safety and immunogenicity of meningococcus serogroup C conjugate vaccine administered as a primary or booster vaccination to healthy four-year-old children
J McVernon et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2002)
The UK Hib vaccine experience
PT Heath et al.
ARCHIVES OF DISEASE IN CHILDHOOD (2002)
Carriage of serogroup C meningococci 1 year after meningococcal C conjugate polysaccharide vaccination
MCJ Maiden et al.
LANCET (2002)
Antibody response to an eleven valent diphtheria- and tetanus-conjugated pneumococcal conjugate vaccine in Filipino infants
T Puumalainen et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2002)
Safety, tolerability and immunogenicity of low dose Haemophilus influenzae type b conjugated to the outer membrane protein complex of Neisseria meningitidis group B
EL Anderson et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2002)
Reduction of nasopharyngeal carriage of Streptococcus pneumoniae after administration of a 9-valent pneumococcal conjugate vaccine to toddlers attending day care centers
R Dagan et al.
JOURNAL OF INFECTIOUS DISEASES (2002)
Postlicensure evaluation of the effectiveness of seven valent pneumococcal conjugate vaccine
SB Black et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2001)
Avidity and subclasses of IgG after immunization of infants with an 11-valent pneumococcal conjugate vaccine with or without aluminum adjuvant
T Wuorimaa et al.
JOURNAL OF INFECTIOUS DISEASES (2001)
Novel vaccine strategies to T-independent antigens
GB Lesinski et al.
JOURNAL OF MICROBIOLOGICAL METHODS (2001)
Planning, registration, and implementation of an immunisation campaign against meningococcal serogroup C disease in the UK: a success story
E Miller et al.
VACCINE (2001)
Serum and salivary anti-capsular antibodies in infants and children vaccinated with octavalent pneumococcal conjugate vaccines, PncD and PncT
A Nurkka et al.
VACCINE (2001)
Primary and booster mucosal immune responses to meningococcal group A and C conjugate and polysaccharide vaccines administered to university students in the United Kingdom
Q Zhang et al.
INFECTION AND IMMUNITY (2001)
Tolerability and immunogenicity of an eleven-valent pneumococcal conjugate vaccine healthy toddlers
T Wuorimaa et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2001)
Efficacy of a pneumococcal conjugate vaccine against acute otitis media
J Eskola et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Safety and immunogenicity of four doses of Neisseria meningitidis group C vaccine conjugated to CRM197 in United States infants
MB Rennels et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2001)
Efficacy of meningococcal serogroup C conjugate vaccine in teenagers and toddlers in England
ME Ramsay et al.
LANCET (2001)
Serum and salivary anti-capsular antibodies in infants and children immunized with the heptavalent pneumococcal conjugate vaccine
A Nurkka et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2001)
Ability of 3 different meningococcal C conjugate vaccines to induce immunologic memory after a single dose in UK toddlers
P Richmond et al.
JOURNAL OF INFECTIOUS DISEASES (2001)
Immunologic memory 5 years after meningococcal A/C conjugate vaccination in infancy
J MacLennan et al.
JOURNAL OF INFECTIOUS DISEASES (2001)
Antibody concentration and clinical protection after Hib conjugate vaccination in the United Kingdom
PT Heath et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2000)
Prevention of Haemophilus influenzae type b colonization by vaccination:: Correlation with serum anti-capsular IgG concentration
J Fernandez et al.
JOURNAL OF INFECTIOUS DISEASES (2000)
Primary and booster salivary antibody responses to a 7-valent pneumococcal conjugate vaccine in infants
S Choo et al.
JOURNAL OF INFECTIOUS DISEASES (2000)
Immunogenicity and reactogenicity of a pneumococcal conjugate vaccine administered combined with a Haemophilus influenzae type b conjugate vaccine in United Kingdom infants
S Choo et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2000)
Estimation of the indirect effect of Haemophilus influence type b conjugate vaccine in an American Indian population
LH Moulton et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2000)
Immunogenicity of a heptavalent pneumococcal conjugate vaccine in Apache and Navajo Indian, Alaska Native, and non-Native American children aged <2 years
KM Miernyk et al.
CLINICAL INFECTIOUS DISEASES (2000)
A high degree of natural immunologic priming to the capsular polysaccharide may not prevent Haemophilus influenzae type b meningitis
P Anderson et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2000)
Safety, immunogenicity, and induction of immunologic memory by a serogroup C meningococcal conjugate vaccine in infants - A randomized controlled trial
JM MacLennan et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2000)
A comparison of multiple regimens of pneumococcal polysaccharide-meningococcal outer membrane protein complex conjugate vaccine and pneumococcal polysaccharide vaccine in toddlers
MD Blum et al.
VACCINE (2000)
Diminution of the anti-polyribosylribitol phosphate response to a combined diphtheria-tetanus-acellular pertussis/Haemophilus influenzae type b vaccine by concurrent inactivated poliovirus vaccination
MB Rennels et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2000)
Safety and immunogenicity of a nonavalent pneumococcal vaccine conjugated to CRM197 administered simultaneously but in a separate syringe with diphtheria, tetanus and pertussis vaccines in Gambian infants
SK Obaro et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2000)
Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children
S Black et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2000)
Safety and immunogenicity of three doses of a Neisseria meningitidis A+C diphtheria conjugate vaccine in infants from Niger
G Campagne et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2000)
Salivary anti-capsular antibodies in infants and children immunised with Streptococcus pneumoniae capsular polysaccharides conjugated to diphtheria or tetanus toxoid
M Korkeila et al.
VACCINE (2000)
Share Paper
